本页面由Tiger Trade Technology Pte. Ltd.提供服务

MEI Pharma

3.07
0.0000
成交量:- -
成交额:1,212.12万
市值:1.01亿
市盈率:-0.65
高:3.07
开:3.07
低:3.07
收:3.07
52周最高:9.00
52周最低:1.46
股本:3,283.77万
流通股本:3,165.72万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-4.7521
每股收益(LYR):2.67
净资产收益率:-89.74%
总资产收益率:-23.23%
市净率:5.16
市盈率(LYR):1.15

数据加载中...

2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/10/27

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/10/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/13

SEC问询函

Form CORRESP - Correspondence
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/29

SEC问询函

Form CORRESP - Correspondence
2023/09/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/09/26

重要事件披露

Form 8-K - Current report
2023/09/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/18

SEC问询函

Form CORRESP - Correspondence
2023/09/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/28

重要事件披露

Form 8-K - Current report
2023/07/24

重要事件披露

Form 8-K - Current report
2023/07/20

企业合并公告

Form 425 - Prospectuses and communications, business combinations